Archives - December 04, 2020

Total Coronavirus cases in India surges past 95 Lakhs

Covid Cases Cross 95 Lakhs in India, 90 Lakh recovered so far...
Dec 04

Karnataka releases Rs 300 crores for Covid-19 vaccine trials

Karnataka prepares for vaccine tri...
Dec 04

AbbVie and Frontier Medicines establish global partnership for research and development

The partnership will address novel therapies and E3 Degraders against difficult-to-drug targets...
Dec 04

Delivering quality, affordable and accessible health care in the UAE by Vikas Katoch, COO, Right Health

...
Dec 04

Make maximum use of digital technology says Anil Joshi, Managing Partner, Unicorn India Ventures

...
Dec 04

Catalyst Biosciences receives FDA Fast track designation for subcutaneous MarzAA

MarzAA for the treatment of episodic bleeding in subjects with Hemophilia A or B with inhibitors ...
Dec 04

Gujarat records 1540 new cases of COVID-19

Gujarat reports fresh coronavirus cases from Ahmedabad and Surat...
Dec 04

COVID-19 recovery rate in Bihar improves to 97.12 pct

In Bihar, the COVID-19 recovery rate has improved to 97.12 percent. This is 3.01 percent more than the national average....
Dec 04

India’s Active Caseload further dips to 4.35% of Total Cases

India’s active caseload has fallen to the 4.35% mark today from 4.44% yesterday....
Dec 04

Britain to cover COVID-19 vaccine side-effects under damages scheme

Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines under an existing program....
Dec 04

Over 11,70,000 samples tested for COVID-19 across country in last 24 hours

Over 11 lakh 70 thousand COVID samples were tested in the country in the last 24 hours. With this, the cumulative testing figure has reached ...
Dec 04

COVID-19 recovery rate in country improves to 94.20 pct

India has leaped across a significant milestone in its fight against COVID. With the cumulative recovery of over 90 lakh people so far, the recovery ...
Dec 04

1450 new cases of COVID-19 reported in Madhya Pradesh

In Madhya Pradesh, the number of COVID-19 cases in the state climbed up to around 2 lakh 10 thousand after 1450 new cases were ...
Dec 04

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application

Rhizen today announced the approval of IND application by the U.S. FDA to study its oral DHODH inhibitor for SARS-CoV-2 infection....
Dec 04

PharmaEngine, Inc. collaborates with Sentinel Oncology for SOL-578, a Chk1 inhibitor

PharmaEngine, Inc. and Sentinel Oncology Limited enter into an exclusive collaboration and license agreement for SOL-578, a Chk1 inhibitor ...
Dec 04

Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India

Zydus Cadila, had received an approval from the Drugs Controller General of India to start the Phase 3 clinical trial in COVID-19 patients with ...
Dec 04

Study shows personalized provider navigation using machine intelligence may reduce post-surgical hospitalizations and lower costs

The results showed that patients treated by hospitals ranked highly for a particular encounter by the machine intelligence–based algorithm experienced better health outcomes and ...
Dec 04

I2O Therapeutics receives strategic investment from Colorcon Ventures

Colorcon will collaborate with i2O to accelerate i2O’s research and development efforts...
Dec 04

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European ...
Dec 04

Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy

Shape Therapeutics, announces today the unveiling of the AAVidTM capsid discovery platform and results from its first AAV5 variant library in a non-human primate ...
Dec 04

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-...
Dec 04

Odisha crosses milestone in conducting over 6 million tests for COVID-19

Odisha has crossed another milestone in conducting over 6 million tests for covid-19. ...
Dec 04

Telangana reports 631 fresh cases of COVID-19

Telangana reported 631 fresh COVID cases during the past 24 hours. With this, the total COVID cases reported in the state has gone up to ...
Dec 04

Covid technical Advisory panel advises Karnataka health dept to be prepared for 2nd wave of COVID-19 pandemic

The Covid technical Advisory Committee in Karnataka has advised the state health department to be prepared to deal with a second wave of a pandemic ...
Dec 04

24 Stories found!